Vitamin B6 PMS Meta-analysis: What the Evidence Says

Quick Answer

Vitamin B6 PMS Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• It has been associated with reduced physical performance, diminish energy levels, and increased level of depression and anxiety. [Sharifipour Foruzan (2025); evidence level 1]
• Studies have explored the efficacy of vitamin B6 in managing pain associated with carpal tunnel syndrome, diabetic neuropathy, back pain, depression, and migraine headaches. [Sharifipour Foruzan (2025); evidence level 1]
• Some evidence suggests that women with Rh-negative blood type may have a higher likelihood of developing premenstrual symptoms, although mechanistic explanations remain speculative and findings are not yet consistent across studies. [Martire Francesco Giuseppe (2026); evidence level 4]
• High caffeine intake has also been linked to increased PMS risk, possibly through its impact on sleep quality, anxiety, and neuroendocrine regulation. [Martire Francesco Giuseppe (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin B6 PMS meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Sharifipour Foruzan (2025). The effectiveness of vitamin B6 in reducing mastalgia: a systematic review and meta-analysis. DOI: 10.1186/s12905-025-03991-x. PMCID: PMC12403960. PMID: 40898150. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12403960/
• Martire Francesco Giuseppe (2026). Premenstrual Syndrome and Nutritional Factors: A Narrative Review of Current Evidence and Clinical Implications. DOI: 10.3390/jcm15031124. PMCID: PMC12898590. PMID: 41682804. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12898590/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.